This approach was revealed to be an effective self-adjuvant delivery method since a single administration promoted antigen-specific CD4+ and CD8+ T cell proliferation and antibody responses, hampering tumor growth while increasing survival in breast cancer models [116]. The gene discussed is CD8A; the disease is neoplasm.